Program: Spotlight Sessions
Session: The Clone Wars: Myeloid Neoplasia Risk in Clonal Hematopoiesis
Hematology Disease Topics & Pathways:
Research, Clinical trials, Translational Research, Elderly, Clinical Research, Education, Study Population, Human
Session: The Clone Wars: Myeloid Neoplasia Risk in Clonal Hematopoiesis
Hematology Disease Topics & Pathways:
Research, Clinical trials, Translational Research, Elderly, Clinical Research, Education, Study Population, Human
Sunday, December 8, 2024, 4:30 PM-5:45 PM
Disclosures: Gronbaek: Janssen: Research Funding; Otsuka Pharma: Membership on an entity's Board of Directors or advisory committees.
OffLabel Disclosure: I will refer to Clinical trials ongoing in CCUS/LR MDS- metformin , canakinumab, vitamn C, cucumin-IDH inhibitor and others that may be registered in clinical trials. gov before the meeting
See more of: The Clone Wars: Myeloid Neoplasia Risk in Clonal Hematopoiesis
See more of: Spotlight Sessions
See more of: Spotlight Sessions
<< Previous Presentation
|
Next Presentation